Research Paper Volume 16, Issue 9 pp 7596—7621
Investigating gene signatures associated with immunity in colon adenocarcinoma to predict the immunotherapy effectiveness using NFM and WGCNA algorithms
Figure 9. Value of the DPM in predicting immunotherapy outcomes. (A–D) Differences in TIDE, MSI, and T-cell dysfunction and exclusion scores between subgroups; (E) ROC curves comparing prognostic efficacy of prognostic models with those of TIDE and TIS; (F) Differences in risk scores between immune responsive and non-responsive patients (GSE109211 dataset).